GKOS Description — Glaukos Corp

Glaukos is an ophthalmic medical technology and pharmaceutical company focused on developing therapies for the treatment of glaucoma, corneal disorders, and retinal disease. Co. has developed Micro-Invasive Glaucoma Surgery as an alternative to the glaucoma treatment paradigm, a bio-activated pharmaceutical therapy for the treatment of a corneal disorder, keratoconus, as well as a pipeline of sustained pharmaceutical therapies, surgical devices, and implantable biosensors to treat glaucoma progression, corneal disorders such as keratoconus, dry eye and refractive vision correction, and retinal diseases such as neovascular age-related macular degeneration and retinal vein occlusion.

Company Name: 
Glaukos Corp
Medical Instruments & Supplies
Number of ETFs Holding GKOS: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   GKOS Weight   GKOS Amount 
 IJR   0.30%   $193,094,050         
 VTI   0.01%   $79,191,283         
 VB   0.06%   $66,275,714         
 IWM   0.11%   $56,711,942         
 VBK   0.13%   $37,974,104         
 VXF   0.04%   $36,436,326         
 IWO   0.21%   $19,882,335         
 IJT   0.40%   $18,996,377         
 SPSM   0.30%   $15,862,301         
 IHI   0.24%   $14,200,503         
List of all 53 ETFs holding GKOS »
Quotes delayed 20 minutes

Email EnvelopeFree GKOS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Buy (2.90 out of 4)
20th percentile
(ranked lower than approx. 80% of all stocks covered)

Analysts Forecast:
GKOS Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding GKOS | Glaukos Corp | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.